Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Product Detail
Compliance with federal and provincial research regulations rests with the buyer's institution
They are not intended for human or veterinary use and must be handled only by qualified researchers within appropriate laboratory environments
Clinical research has indicated that FOXO4-DRI has shown promise in the following areas: Targets senescent cells FOXO4-DRI is a synthetic peptide designed to target senescent cells, which are damaged cells that stop dividing but resist apoptosis (programmed cell death)
& Sigurdsson, E
It is possible that FGF21 exerts some direct or indirect effect on the GI tract, but experiments directly testing this hypothesis have not been reported to date
US$ 24.66
US$ 22.77
US$ 29.07
US$ 29.05
